Dehydroepiandrosterone (DHEA) and its Sulfate (DHEAS) in Critical Illness
Dehydroepiandrosterone (DHEA) is the most abundant circulating hormone in the human body and can be converted to either androgens or estrogens. It is readily conjugated to its sulfate ester, DHEAS, and they are designated as DHEA(S) here when used together . DHEA has received considerable attention in the lay and scientific press for its anti-aging effects and as mediator of several diseases. A number of reports have suggested that DHEAS levels are inversely related to cardiovascular disease and mortality, but findings have not been consistent . In the USA, DHEA is currently available as an over-the counter drug; as a precursor of testosterone, entitled as a “fountain of youth”  or “the last elixir”.
KeywordsCritical Illness Adrenal Insufficiency Adrenal Androgen Zona Reticularis DHEAS Level
Unable to display preview. Download preview PDF.
- 10.Loria RM, Inge TH, Cook SS, Szakal AK, Regelson W (1988) Protection against acute lethal viral infections with the native steroid dehydroepiandrosterone ( DHEA ). J Med Virol 26: 301–314Google Scholar
- 16.Regelson W, Kalimi M (1994) Dehydroepiandrosterone (DHEA) - the multifunctional steroid. II. Effects on the CNS, cell proliferation, metabolic and vascular, clinical and other effects. Mechanism of action? Ann NY Acad Sci 719: 564–575Google Scholar
- 18.Regelson W, Loria R, Kalimi M (1994) Dehydroepiandrosterone (DHEA) - the “mother steroid”. I. Immunologic action. Ann NY Acad Sci 719: 553–563Google Scholar
- 19.Daynes RA, Araneo BA, Ershler WB, Maloney C, Li GZ, Ryu SY (1993) Altered regulation of IL-6 production with normal aging. Possible linkage to the age-associated decline in dehydroepiandrosterone and its sulfated derivative. J Immunol 150: 5219–5230Google Scholar
- 23.Semple CG, Gray CE, Beastall GH (1987) Adrenal androgens and illness. Acta Endocrinol (Copenh) 116: 155–160Google Scholar
- 28.Schuld A, Mullington J, Friess E, et al (2000) Changes in dehydroepiandrosterone ( DHEA) and DHEA-sulfate plasma levels during experimental endotoxinemia in healthy volunteers. J Clin Endocrinol Metab 85: 4624–4629Google Scholar
- 36.Straub RH, Konecna L, Hrach S, et al (1998) Serum dehydroepiandrosterone (DHEA) and DHEA sulfate are negatively correlated with serum interleukin-6 (IL-6), and DHEA inhibits IL-6 secretion from mononuclear cells in man in vitro: possible link between endocrinosenescence and immunosenescence. J Clin Endocrinol Metab 83: 2012–2017PubMedCrossRefGoogle Scholar
- 39.Araneo B, Daynes R (1995) Dehydroepiandrosterone functions as more than an antiglucocorticoid in preserving immunocompetence after thermal injury. Endocrinology 136: 393401Google Scholar
- 43.Van den Berghe G, de Zegher F, Bouillon R (1998) Clinical review 95: acute and prolonged critical illness as different neuroendocrine paradigms. J Clin Endocrinol Metab 83: 18271834Google Scholar